Findings

What do systematic reviews say?

258 questions · 261 findings · 20 reviews · Hepato-Biliary

Sort:Best matchNewest Highest certainty Download CSV

No studies found 81 · 31%GRADE not reported 4 · 1.5%Very low 146 · 55.9%Low 19 · 7.3%Moderate 9 · 3.4%High 2 · 0.8%

Colchicine vs no intervention

Mortality at maximal · people with primary biliary cholangitis

It is very uncertain whether colchicine changes mortality at maximal compared with no intervention (very low certainty).

1 finding from 1 review

Pharmacological interventions for primary biliary cholangitis 2017 · Cochrane Headline outcomes only
OR 0.77 [0.32, 1.85]
2 studies · 122 participants
Very low

Hepatic resection vs radiofrequency ablation

Overall survival · 578 patients with early HCC

1 finding from 1 review

Radiofrequency (thermal) ablation versus no intervention or other interventions for hepatocellular carcinoma 2013 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 578 participants
Moderate

Percutaneous ethanol injection vs radiofrequency ablation

Local progression · 1088 patients with early HCC

1 finding from 1 review

Radiofrequency (thermal) ablation versus no intervention or other interventions for hepatocellular carcinoma 2013 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 678 participants
Moderate

Percutaneous ethanol injection vs radiofrequency ablation

Rate of complications · 1088 patients with early HCC

1 finding from 1 review

Radiofrequency (thermal) ablation versus no intervention or other interventions for hepatocellular carcinoma 2013 · Cochrane Headline outcomes only
no estimate extracted
6 studies · 1088 participants
Moderate

Percutaneous ethanol injection vs radiofrequency ablation

Length of hospital stay · 1088 patients with early HCC

1 finding from 1 review

Radiofrequency (thermal) ablation versus no intervention or other interventions for hepatocellular carcinoma 2013 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 576 participants
Moderate

Hepatic resection vs radiofrequency ablation

2‐year survival‐ · 578 patients with early HCC

1 finding from 1 review

Radiofrequency (thermal) ablation versus no intervention or other interventions for hepatocellular carcinoma 2013 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 578 participants
Moderate

Hepatic resection vs radiofrequency ablation

Event‐free survival · 578 patients with early HCC

1 finding from 1 review

Radiofrequency (thermal) ablation versus no intervention or other interventions for hepatocellular carcinoma 2013 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 578 participants
Moderate

Hepatic resection vs radiofrequency ablation

Local progression · 578 patients with early HCC

1 finding from 1 review

Radiofrequency (thermal) ablation versus no intervention or other interventions for hepatocellular carcinoma 2013 · Cochrane Headline outcomes only
no estimate extracted
1 study · 168 participants
Low

Hepatic resection vs radiofrequency ablation

Rate of complications · 578 patients with early HCC

1 finding from 1 review

Radiofrequency (thermal) ablation versus no intervention or other interventions for hepatocellular carcinoma 2013 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 578 participants
High

Hepatic resection vs radiofrequency ablation

Length of hospital stay · 578 patients with early HCC

1 finding from 1 review

Radiofrequency (thermal) ablation versus no intervention or other interventions for hepatocellular carcinoma 2013 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 578 participants
High

Percutaneous ethanol injection vs radiofrequency ablation

Overall survival · 1088 patients with early HCC

1 finding from 1 review

Radiofrequency (thermal) ablation versus no intervention or other interventions for hepatocellular carcinoma 2013 · Cochrane Headline outcomes only
no estimate extracted
6 studies · 1088 participants
Moderate

Percutaneous ethanol injection vs radiofrequency ablation

2‐year survival · 1088 patients with early HCC

1 finding from 1 review

Radiofrequency (thermal) ablation versus no intervention or other interventions for hepatocellular carcinoma 2013 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 715 participants
Moderate

Percutaneous ethanol injection vs radiofrequency ablation

Event‐free survival · 1088 patients with early HCC

1 finding from 1 review

Radiofrequency (thermal) ablation versus no intervention or other interventions for hepatocellular carcinoma 2013 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 949 participants
Moderate

Intervention not reported

Peg interferon vs.control · Participants with recurrent liver graft infection with hepatitis C virus.

It is very uncertain whether the intervention changes peg interferon vs.control (very low certainty).

1 finding from 1 review

Antiviral interventions for liver transplant patients with recurrent graft infection due to hepatitis C virus 2013 · Cochrane Headline outcomes only
RR 0.48 [0.05, 5.09]
1 study · 65 participants
Very low

Intervention not reported

Peg interferon plus ribavirin vs.control · Participants with recurrent liver graft infection with hepatitis C virus.

It is very uncertain whether the intervention changes peg interferon plus ribavirin vs.control (very low certainty).

1 finding from 1 review

Antiviral interventions for liver transplant patients with recurrent graft infection due to hepatitis C virus 2013 · Cochrane Headline outcomes only
RR 3 [0.13, 70.53]
1 study · 54 participants
Very low

Intervention not reported

Ribavirin plus peg interferon vs.peg interferon · Participants with recurrent liver graft infection with hepatitis C virus.

It is very uncertain whether the intervention changes ribavirin plus peg interferon vs.peg interferon (very low certainty).

1 finding from 1 review

Antiviral interventions for liver transplant patients with recurrent graft infection due to hepatitis C virus 2013 · Cochrane Headline outcomes only
RR 0.5 [0.05, 5.2]
2 studies · 98 participants
Very low

Intervention not reported

Interferon vs.control · Participants with recurrent liver graft infection with hepatitis C virus.

It is very uncertain whether the intervention changes interferon vs.control (very low certainty).

1 finding from 1 review

Antiviral interventions for liver transplant patients with recurrent graft infection due to hepatitis C virus 2013 · Cochrane Headline outcomes only
RR 1.67 [0.08, 33.75]
1 study · 12 participants
Very low

Intervention not reported

Interferon plus ribavirin vs.control · Participants with recurrent liver graft infection with hepatitis C virus.

It is very uncertain whether the intervention changes interferon plus ribavirin vs.control (very low certainty).

1 finding from 1 review

Antiviral interventions for liver transplant patients with recurrent graft infection due to hepatitis C virus 2013 · Cochrane Headline outcomes only
RR 0.29 [0.01, 6.74]
1 study · 52 participants
Very low

Intervention not reported

Ribavirin vs.interferon · Participants with recurrent liver graft infection with hepatitis C virus.

1 finding from 1 review

Antiviral interventions for liver transplant patients with recurrent graft infection due to hepatitis C virus 2013 · Cochrane Headline outcomes only
no estimate extracted
1 study · 30 participants
Very low

Intervention not reported

Ribavirin vs.placebo · Participants with recurrent liver graft infection with hepatitis C virus.

1 finding from 1 review

Antiviral interventions for liver transplant patients with recurrent graft infection due to hepatitis C virus 2013 · Cochrane Headline outcomes only
no estimate extracted
1 study · 77 participants
Very low